145 related articles for article (PubMed ID: 9754918)
21. The angiotensin II AT1 receptor antagonist irbesartan prevents thromboxane A2-induced vasoconstriction in the rat hind-limb vascular bed in vivo.
Fukuhara M; Neves LA; Li P; Diz DI; Ferrario CM; Brosnihan KB
J Hypertens; 2001 Mar; 19(3 Pt 2):561-6. PubMed ID: 11327630
[TBL] [Abstract][Full Text] [Related]
22. Selective and potent inhibitory effect of docosahexaenoic acid (DHA) on U46619-induced contraction in rat aorta.
Sato K; Chino D; Kobayashi T; Obara K; Miyauchi S; Tanaka Y
J Smooth Muscle Res; 2013; 49():63-77. PubMed ID: 24304639
[TBL] [Abstract][Full Text] [Related]
23. Testosterone treatment enhances thromboxane A2 mimetic induced coronary artery vasoconstriction in guinea pigs.
Schrör K; Morinelli TA; Masuda A; Matsuda K; Mathur RS; Halushka PV
Eur J Clin Invest; 1994 Feb; 24 Suppl 1():50-2. PubMed ID: 8013532
[TBL] [Abstract][Full Text] [Related]
24. Modulation by adenosine of thromboxane A2 receptor-mediated constriction in the human umbilical artery.
Di Grande A; Malatino LS; Boura AL; Read MA; Walters WA
Int J Clin Pharmacol Ther; 1994 Jul; 32(7):344-6. PubMed ID: 7952795
[TBL] [Abstract][Full Text] [Related]
25. Human internal mammary artery contraction by isoprostaglandin f(2alpha) type-III [8-iso-prostaglandin F(2alpha)].
Cracowski JL; Stanke-Labesque F; Devillier P; Chavanon O; Hunt M; Souvignet C; Bessard G
Eur J Pharmacol; 2000 May; 397(1):161-8. PubMed ID: 10844110
[TBL] [Abstract][Full Text] [Related]
26. Angiopeptin, a somatostatin analogue, inhibits rat coronary artery and aorta smooth muscle cell proliferation induced by the thromboxane A2 mimetic U46619.
Zhao Y; Foegh ML
Prostaglandins; 1997 Nov; 54(5):781-93. PubMed ID: 9491208
[TBL] [Abstract][Full Text] [Related]
27. Characterization of excitatory prostanoid receptors in the human umbilical artery in vitro.
Boersma JI; Janzen KM; Oliveira L; Crankshaw DJ
Br J Pharmacol; 1999 Dec; 128(7):1505-12. PubMed ID: 10602330
[TBL] [Abstract][Full Text] [Related]
28. The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats.
Tang EH; Jensen BL; Skott O; Leung GP; Feletou M; Man RY; Vanhoutte PM
Cardiovasc Res; 2008 Apr; 78(1):130-8. PubMed ID: 18093985
[TBL] [Abstract][Full Text] [Related]
29. Benextramine acts as an irreversible noncompetitive antagonist of U46619-mediated contraction of the rat small mesenteric artery.
Van der Graaf PH; Stam WB; Saxena PR
Eur J Pharmacol; 1996 Apr; 300(3):211-4. PubMed ID: 8739210
[TBL] [Abstract][Full Text] [Related]
30. Furosemide inhibits thromboxane A2-induced contraction in isolated human internal mammary artery and saphenous vein.
Stanke-Labesque F; Cracowski JL; Bedouch P; Chavanon O; Magne JL; Bessard G; Devillier P
J Cardiovasc Pharmacol; 2000 Apr; 35(4):531-7. PubMed ID: 10774781
[TBL] [Abstract][Full Text] [Related]
31. Effects of KP-496, a novel dual antagonist for leukotriene D4 and thromboxane A2 receptors, on contractions induced by various agonists in the guinea pig trachea.
Ishimura M; Kataoka S; Suda M; Maeda T; Hiyama Y
Allergol Int; 2006 Dec; 55(4):403-10. PubMed ID: 17130683
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery.
Lydford SJ; McKechnie KC; Dougall IG
Br J Pharmacol; 1996 Jan; 117(1):13-20. PubMed ID: 8825337
[TBL] [Abstract][Full Text] [Related]
33. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
34. On the mechanism of the prolonged action in man of GR32191, a thromboxane receptor antagonist.
Ritter JM; Doktor HS; Benjamin N; Barrow SE; Stewart-Long P
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():351-4. PubMed ID: 1825568
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of vasoconstriction by the thromboxane A2 antagonist GR32191B in the human radial artery.
He GW; Yang CQ
Br J Clin Pharmacol; 1999 Aug; 48(2):207-15. PubMed ID: 10417498
[TBL] [Abstract][Full Text] [Related]
36. Antiplatelet effect of Z-335, a new orally active and long-lasting thromboxane receptor antagonist.
Tanaka T; Fukuta Y; Higashino R; Sato R; Nomura Y; Fukuda Y; Ito S; Takei M; Kurimoto T; Tamaki H
Eur J Pharmacol; 1998 Sep; 357(1):53-60. PubMed ID: 9788773
[TBL] [Abstract][Full Text] [Related]
37. Thromboxane A2-induced inhibition of voltage-gated K+ channels and pulmonary vasoconstriction: role of protein kinase Czeta.
Cogolludo A; Moreno L; Bosca L; Tamargo J; Perez-Vizcaino F
Circ Res; 2003 Oct; 93(7):656-63. PubMed ID: 12970114
[TBL] [Abstract][Full Text] [Related]
38. Glibenclamide inhibits agonist-induced vasoconstriction of placental chorionic plate arteries.
Wareing M; Greenwood SL; Fyfe GK; Baker PN; Taggart MJ
Placenta; 2006; 27(6-7):660-8. PubMed ID: 16026833
[TBL] [Abstract][Full Text] [Related]
39. Preliminary assessment of a novel thromboxane A2 receptor-blocking drug, GR32191, in healthy subjects.
Thomas M; Lumley P
Circulation; 1990 Jan; 81(1 Suppl):I53-8; discussion I59-60. PubMed ID: 2136818
[TBL] [Abstract][Full Text] [Related]
40. Actions of 8 epi prostaglandin F2alpha on isolated rat aorta.
Kromer BM; Tippins JR
J Cardiovasc Pharmacol; 1998 Sep; 32(3):471-8. PubMed ID: 9733362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
